SK Discovery | Sustainability Performance
Engages in research, development, and production of healthcare and pharmaceutical solutions. Provides technical support, clinical collaboration, and supply chain management to support medical and biotechnological applications.
1969
South Korea
51 - 200 employees
Chemicals
$1B - 10B in revenue
$25M - 100M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#11273
Overallⓘ#181
in South Koreaⓘ#342
in ChemicalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsEnergy consumptionWaste ManagementWater ManagementFinancial Data
Business performanceCapital & innovationAnalyst projections
Leading
Controversy level
- SK Discovery Co Ltd, Korean SK Group holding (Chey Taewon family), has faced sustained Korean FSC regulatory enforcement scrutiny over the contested 2024 Chey family controlling shareholder governance complexity following the Chey Taewon divorce settlement ruling affecting Korean SK Group institutional minority shareholders, plus periodic class actions over chaebol intragroup transactions.
